Back to Search
DEVANGI DESAI, MD
MD
Internal Medicine Physician
NPI: 1710155163IndividualAccepts Medicare
Education
OTHER
Class of 1998
Research & Publications (20)
Anaphylactic reaction to anakinra in a rheumatoid arthritis patient intolerant to multiple nonbiologic and biologic disease-modifying antirheumatic drugs.
PMID 19417117·Ann Pharmacother·2009
5-case
The prevalence of BRCA1 mutations among young women with triple-negative breast cancer.
PMID 19298662·BMC Cancer·2009
8-other
Cellular responses to cancer chemopreventive agent D,L-sulforaphane in human prostate cancer cells are initiated by mitochondrial reactive oxygen species.
PMID 19384467·Pharm Res·2009
8-other
The selenium analog of the chemopreventive compound S,S'-(1,4-phenylenebis[1,2-ethanediyl])bisisothiourea is a remarkable inducer of apoptosis and inhibitor of cell growth in human non-small cell lung cancer.
PMID 19497413·Chem Biol Interact·2009
8-other
Sulforaphane inhibits prostate carcinogenesis and pulmonary metastasis in TRAMP mice in association with increased cytotoxicity of natural killer cells.
PMID 19223537·Cancer Res·2009
7-preclinical
Activation of glycolysis and apoptosis in glycogen storage disease type Ia.
PMID 19419892·Mol Genet Metab·2009
7-preclinical
Targeting Akt3 signaling in malignant melanoma using isoselenocyanates.
PMID 19208796·Clin Cancer Res·2009
4-observational
The molecular basis of cancer and the development of targeted therapy.
PMID 19186227·Surg Clin North Am·2009
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 6630 S MCCARRAN BLVD STE 9
RENO, NV 89509 - Phone
- (775) 204-4000
Quick Facts
- NPI
- 1710155163
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 2
- Years in Practice
- 28
- Publications
- 20
Are you this provider?
Claim Your Profile